Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1259)
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
14,565
Price
$78.41
Total Value
$1.14M
Shares Held After
245,571
% of Holdings
5.6%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President & Immunovant CEO
Shares
46,234
Price
$33.51
Total Value
$1.55M
Shares Held After
1,613,063
% of Holdings
2.8%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President & Immunovant CEO
Shares
153,766
Price
$33.05
Total Value
$5.08M
Shares Held After
1,659,297
% of Holdings
8.5%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
6,696
Price
$50.00
Total Value
$334.80K
Shares Held After
519,227
% of Holdings
1.3%
Praxis Precision Medicines, Inc. (PRAX)
DeSimone Jill — Director
Shares
837
Price
$315.70
Total Value
$264.25K
Shares Held After
2,337
% of Holdings
26.4%
Praxis Precision Medicines, Inc. (PRAX)
DeSimone Jill — Director
Shares
1,279
Price
$314.90
Total Value
$402.76K
Shares Held After
3,174
% of Holdings
28.7%
Praxis Precision Medicines, Inc. (PRAX)
DeSimone Jill — Director
Shares
504
Price
$313.66
Total Value
$158.09K
Shares Held After
4,453
% of Holdings
10.2%
Praxis Precision Medicines, Inc. (PRAX)
DeSimone Jill — Director
Shares
1,004
Price
$312.83
Total Value
$314.08K
Shares Held After
4,957
% of Holdings
16.8%
Praxis Precision Medicines, Inc. (PRAX)
DeSimone Jill — Director
Shares
2,854
Price
$311.91
Total Value
$890.20K
Shares Held After
5,961
% of Holdings
32.4%
Praxis Precision Medicines, Inc. (PRAX)
DeSimone Jill — Director
Shares
1,750
Price
$310.89
Total Value
$544.06K
Shares Held After
8,815
% of Holdings
16.6%
Praxis Precision Medicines, Inc. (PRAX)
DeSimone Jill — Director
Shares
999
Price
$309.38
Total Value
$309.07K
Shares Held After
10,565
% of Holdings
8.6%
Praxis Precision Medicines, Inc. (PRAX)
DeSimone Jill — Director
Shares
1,240
Price
$308.24
Total Value
$382.22K
Shares Held After
11,564
% of Holdings
9.7%
Praxis Precision Medicines, Inc. (PRAX)
DeSimone Jill — Director
Shares
683
Price
$306.77
Total Value
$209.52K
Shares Held After
12,804
% of Holdings
5.1%
Praxis Precision Medicines, Inc. (PRAX)
DeSimone Jill — Director
Shares
320
Price
$305.31
Total Value
$97.70K
Shares Held After
13,487
% of Holdings
2.3%
Praxis Precision Medicines, Inc. (PRAX)
DeSimone Jill — Director
Shares
120
Price
$303.13
Total Value
$36.38K
Shares Held After
13,807
% of Holdings
0.9%
Praxis Precision Medicines, Inc. (PRAX)
DeSimone Jill — Director
Shares
10
Price
$301.44
Total Value
$3.01K
Shares Held After
13,927
% of Holdings
0.1%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
4,922
Price
$85.03
Total Value
$418.52K
Shares Held After
60,137
% of Holdings
7.6%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
401
Price
$85.01
Total Value
$34.09K
Shares Held After
60,137
% of Holdings
0.7%
Revolution Medicines, Inc. (RVMD)
Anders Jack — Chief Financial Officer
Shares
300
Price
$170.32
Total Value
$51.10K
Shares Held After
123,269
% of Holdings
0.2%
Revolution Medicines, Inc. (RVMD)
Anders Jack — Chief Financial Officer
Shares
5,651
Price
$169.24
Total Value
$956.40K
Shares Held After
123,569
% of Holdings
4.4%
Revolution Medicines, Inc. (RVMD)
Anders Jack — Chief Financial Officer
Shares
9,496
Price
$168.20
Total Value
$1.60M
Shares Held After
129,220
% of Holdings
6.8%
Revolution Medicines, Inc. (RVMD)
Anders Jack — Chief Financial Officer
Shares
4,553
Price
$167.34
Total Value
$761.92K
Shares Held After
138,716
% of Holdings
3.2%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
19,973
Price
$21.02
Total Value
$419.83K
Shares Held After
1,086,063
% of Holdings
1.8%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
25,397
Price
$21.02
Total Value
$533.84K
Shares Held After
1,484,760
% of Holdings
1.7%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
50,530
Price
$21.02
Total Value
$1.06M
Shares Held After
4,755,109
% of Holdings
1.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,029
Price
$101.14
Total Value
$205.21K
Shares Held After
597,047
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
14,490
Price
$101.14
Total Value
$1.47M
Shares Held After
3,343,343
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
14,513
Price
$100.42
Total Value
$1.46M
Shares Held After
599,076
% of Holdings
2.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
103,688
Price
$100.42
Total Value
$10.41M
Shares Held After
3,357,833
% of Holdings
3.0%
Royalty Pharma plc (RPRX)
Urist Marshall — EVP, Research & Investments
Shares
9,098
Price
$55.18
Total Value
$502.07K
Shares Held After
9,099
% of Holdings
50.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$553.24
Total Value
$221.30K
Shares Held After
40,513
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$551.76
Total Value
$198.64K
Shares Held After
40,913
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,003
Price
$551.03
Total Value
$552.68K
Shares Held After
41,273
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,357
Price
$550.06
Total Value
$746.43K
Shares Held After
42,276
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,300
Price
$548.74
Total Value
$713.36K
Shares Held After
43,633
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,086
Price
$548.01
Total Value
$1.14M
Shares Held After
44,933
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,234
Price
$547.03
Total Value
$1.22M
Shares Held After
47,019
% of Holdings
4.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
760
Price
$545.93
Total Value
$414.90K
Shares Held After
49,253
% of Holdings
1.5%
CG Oncology, Inc. (CGON)
POST LEONARD E — Director
Shares
5,000
Price
$70.00
Total Value
$350.00K
Shares Held After
0
% of Holdings
100.0%
Lite Strategy, Inc. (LITS)
Flynn James P — Director
Shares
25,000
Price
$0.86
Total Value
$21.39K
Shares Held After
125,000
% of Holdings
20.0%
Monte Rosa Therapeutics, Inc. (GLUE)
Janku Filip — Chief Medical Officer
Shares
30,000
Price
$21.42
Total Value
$642.68K
Shares Held After
59,992
% of Holdings
33.3%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
115,000
Price
$0.04
Total Value
$5.17K
Shares Held After
93,884,319
% of Holdings
0.1%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Bergmann Anthony — CHIEF FINANCIAL OFFICER
Shares
400
Price
$30.00
Total Value
$12.00K
Shares Held After
11,223
% of Holdings
3.4%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Krasney Karen — EVP, GENERAL COUNSEL
Shares
400
Price
$30.00
Total Value
$12.00K
Shares Held After
30,547
% of Holdings
1.3%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
114
Price
$14.98
Total Value
$1.71K
Shares Held After
169,556
% of Holdings
0.1%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
6,979
Price
$14.60
Total Value
$101.89K
Shares Held After
169,670
% of Holdings
4.0%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
666
Price
$14.98
Total Value
$9.98K
Shares Held After
793,328
% of Holdings
0.1%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
40,679
Price
$14.60
Total Value
$593.91K
Shares Held After
793,994
% of Holdings
4.9%
BridgeBio Pharma, Inc. (BBIO)
Cook Jennifer E. — Director
Shares
37,167
Price
$70.00
Total Value
$2.60M
Shares Held After
8,383
% of Holdings
81.6%
Arcus Biosciences, Inc. (RCUS)
Jaen Juan C. — President
Shares
6,431
Price
$29.66
Total Value
$190.74K
Shares Held After
890,809
% of Holdings
0.7%
Showing 1–50 of 1259 transactions (page 1 of 26)